Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 3736 AL 3750

Neurological Disorders Associated with Glutamic Acid Decarboxylase Antibodies

Herard K, Khanni JL, Alusma-Hibbert K, Samuels CR, Espinosa PS.

Cureus. 2019 May 23;11(5):e4738. doi: 10.7759/cureus.4738.

Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis

Poorthuis MHF, van Rooij JLM, Koch AH, Verdonkschot AEM, Leembruggen MM, Titulaer MJ.

Neurol Neuroimmunol Neuroinflamm. 2019 Jun 4;6(4):e579. doi: 10.1212/NXI.0000000000000579. eCollection 2019 Jul.

Ataxia

Kuo SH.

Continuum (Minneap Minn). 2019 Aug;25(4):1036-1054. doi: 10.1212/CON.0000000000000753.

microRNA dysregulation in neurodegenerative diseases: A systematic review

Juźwik CA, S Drake S, Zhang Y, Paradis-Isler N, Sylvester A, Amar-Zifkin A, Douglas C, Morquette B, Moore CS, Fournier AE.

Prog Neurobiol. 2019 Nov;182:101664. doi: 10.1016/j.pneurobio.2019.101664. Epub 2019 Jul 26.

Robot-assisted gait training for balance and lower extremity function in patients with infratentorial stroke: a single-blinded randomized controlled trial

Kim HY, Shin JH, Yang SP, Shin MA, Lee SH.

J Neuroeng Rehabil. 2019 Jul 29;16(1):99. doi: 10.1186/s12984-019-0553-5.

Posterior fossa pilocytic astrocytoma presenting with opisthotonus in an infant - A case report

Yates C, Lackey A, Campbell R, McEniery J.

J Clin Neurosci. 2019 Oct;68:338-341. doi: 10.1016/j.jocn.2019.07.052. Epub 2019 Jul 26.

Emerging Perspectives on DNA Double-strand Breaks in Neurodegenerative Diseases

Zhu LS, Wang DQ, Cui K, Liu D, Zhu LQ.

Curr Neuropharmacol. 2019;17(12):1146-1157. doi: 10.2174/1570159X17666190726115623.

DNA Damage Repair in Huntington's Disease and Other Neurodegenerative Diseases

Maiuri T, Suart CE, Hung CLK, Graham KJ, Barba Bazan CA, Truant R.

Neurotherapeutics. 2019 Oct;16(4):948-956. doi: 10.1007/s13311-019-00768-7.

Patients with laboratory evidence of West Nile virus disease without reported fever

Landry K, Rabe IB, Messenger SL, Hacker JK, Salas ML, Scott-Waldron C, Haydel D, Rider E, Simonson S, Brown CM, Smole SC, Neitzel DF, Schiffman EK, Strain AK, Vetter S, Fischer M, Lindsey NP.

Epidemiol Infect. 2019 Jan;147:e219. doi: 10.1017/S0950268819001079.

Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis

Nishigori R, Warabi Y, Shishido-Hara Y, Nakamichi K, Nakata Y, Komori T, Isozaki E.

Intern Med. 2019 Nov 15;58(22):3323-3329. doi: 10.2169/internalmedicine.3038-19. Epub 2019 Jul 31.

Concurrent leukoencephalomyelitis and polyneuritis in a Maltese terrier: resembling combined central and peripheral demyelination in humans

Li WT, Wu CC, Tu YC, Huang WH, Chang HW, Pang VF, Jeng CR, Liu CH.

J Vet Med Sci. 2019 Oct 10;81(9):1373-1378. doi: 10.1292/jvms.18-0696. Epub 2019 Jul 30.

Cerebellar Involvement in DYT-THAP1 Dystonia

Nikolov P, Hassan SS, Aytulun A, Hartmann CJ, Kohlhase J, Schnitzler A, Albrecht P, Minnerop M, Groiss SJ.

Cerebellum. 2019 Oct;18(5):969-971. doi: 10.1007/s12311-019-01062-0.

Novel POLR1C mutation in RNA polymerase III-related leukodystrophy with severe myoclonus and dystonia

Kraoua I, Karkar A, Drissi C, Benrhouma H, Klaa H, Samaan S, Renaldo F, Elmaleh M, Ben Hamouda M, Abdelhak S, Boespflug-Tanguy O, Ben Youssef-Turki I, Dorboz I.

Mol Genet Genomic Med. 2019 Sep;7(9):e914. doi: 10.1002/mgg3.914. Epub 2019 Jul 31.

Essential Role of Ubiquitin-Fold Modifier 1 Conjugation in DNA Damage Response

Fang Z, Pan Z.

DNA Cell Biol. 2019 Oct;38(10):1030-1039. doi: 10.1089/dna.2019.4861. Epub 2019 Aug 6.

[Dandy-Walker malformation. The CRIT protocol. A propos of a case]

Rojas Martínez K, Neri Gámez S, Díaz Gómez A.

Rehabilitacion (Madr). 2019 Jul-Sep;53(3):211-213. doi: 10.1016/j.rh.2018.09.002. Epub 2019 Jul 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias